Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

INTRODUCTION: Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Mitra, Souvik, Jain, Amish, Ting, Joseph Y., Ben Fadel, Nadya, Drolet, Christine, Abou Mehrem, Ayman, Soraisham, Amuchou, Jasani, Bonny, Louis, Deepak, Lapointe, Anie, Dorling, Jon, Khurshid, Faiza, Hyderi, Abbas, Kumaran, Kumar, Bodani, Jaya, Weisz, Dany, Alvaro, Ruben, Adie, Mohammed, Stavel, Miroslav, Morin, Alyssa, Bhattacharya, Soume, Kanungo, Jaideep, Canning, Rody, Ye, Xiang Y, Hatfield, Tara, Gardner, Courtney E, Shah, Prakesh
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Paediatrics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103361/
https://ncbi.nlm.nih.gov/pubmed/33952559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2021-050682
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados